These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3902553)
1. Effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography. Determination of threshold, dose-response relationships and comparison with intraduodenal bilirubin output. Hopman WP; Kerstens PJ; Jansen JB; Rosenbusch G; Lamers CB Gastroenterology; 1985 Dec; 89(6):1242-7. PubMed ID: 3902553 [TBL] [Abstract][Full Text] [Related]
2. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. Kerstens PJ; Lamers CB; Jansen JB; de Jong AJ; Hessels M; Hafkenscheid JC Life Sci; 1985 Feb; 36(6):565-9. PubMed ID: 3968978 [TBL] [Abstract][Full Text] [Related]
3. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous measurement of gallbladder emptying with cholescintigraphy and US during infusion of physiologic doses of cholecystokinin: a comparison. Masclee AA; Hopman WP; Corstens FH; Rosenbusch G; Jansen JB; Lamers CB Radiology; 1989 Nov; 173(2):407-10. PubMed ID: 2678254 [TBL] [Abstract][Full Text] [Related]
5. Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans. Thimister PW; Hopman WP; Tangerman A; Rosenbusch G; Willems HL; Jansen JB Hepatology; 1998 Dec; 28(6):1454-60. PubMed ID: 9828206 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329. Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709 [TBL] [Abstract][Full Text] [Related]
8. Differences in cholecystokinin release and gallbladder contraction between emulsified and nonemulsified long-chain triglycerides. Ledeboer M; Masclee AA; Biemond I; Lamers CB JPEN J Parenter Enteral Nutr; 1999; 23(4):203-6. PubMed ID: 10421388 [TBL] [Abstract][Full Text] [Related]
9. Role of cholecystokinin and the cholinergic system in intestinal stimulation of gallbladder contraction in man. Hopman WP; Jansen JB; Rosenbusch G; Lamers CB Hepatology; 1990 Feb; 11(2):261-5. PubMed ID: 2307405 [TBL] [Abstract][Full Text] [Related]
10. Effect of increasing oral doses of loperamide on gallbladder motility in man. Hopman WP; Rosenbusch G; Jansen JB; Lamers CB Br J Clin Pharmacol; 1990 Jan; 29(1):55-60. PubMed ID: 2297461 [TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man. Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057 [TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans. Shirohara H; Tabaru A; Otsuki M J Gastroenterol; 1996 Aug; 31(4):572-7. PubMed ID: 8844480 [TBL] [Abstract][Full Text] [Related]
13. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers. Schwarzendrube J; Niederau M; Lüthen R; Niederau C Gastroenterology; 1991 Jun; 100(6):1683-90. PubMed ID: 2019374 [TBL] [Abstract][Full Text] [Related]
14. Gallbladder sensitivity to cholecystokinin in coeliac disease. Correlation of gallbladder contraction with plasma cholecystokinin-like immunoreactivity during infusion of cerulein. Masclee AA; Jansen JB; Driessen WM; Geuskens LM; Lamers CB Scand J Gastroenterol; 1991 Dec; 26(12):1279-84. PubMed ID: 1763298 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of pancreaticobiliary secretion by loperamide in humans. Thimister PW; Hopman WP; van Roermund RF; Willems HL; Rosenbusch G; Woestenborghs R; Jansen JB Hepatology; 1997 Aug; 26(2):256-61. PubMed ID: 9252131 [TBL] [Abstract][Full Text] [Related]